| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 19 |
| 1 | METHOTREXATE SODIUM | 14 |
| 2 | CYCLOPHOSPHAMIDE | 13 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 5 | METHOTREXATE | 12 |
| 6 | DOXORUBICIN | 11 |
| 7 | PREDNISONE | 10 |
| 8 | ANASTROZOLE | 9 |
| 9 | ANASTROZOLE TABLETS | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EDETATE CALCIUM DISODIUM | 1 | 0.0250 |
| 1 | TEBENTAFUSP | 1 | 0.0017 |
| 2 | DIAZOXIDE | 1 | 0.0014 |
| 3 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 4 | MOSUNETUZUMAB | 1 | 0.0009 |
| 5 | ROPEGINTERFERON ALFA-2B | 1 | 0.0005 |
| 6 | CLOFARABINE | 1 | 0.0004 |
| 7 | GLOFITAMAB | 1 | 0.0004 |
| 8 | ANASTROZOLE TABLETS | 8 | 0.0004 |
| 9 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 25 |
| 1 | Alkylating Drug [EPC] | 14 |
| 2 | Kinase Inhibitor [EPC] | 14 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 4 | Aromatase Inhibitor [EPC] | 10 |
| 5 | Microtubule Inhibitor [EPC] | 10 |
| 6 | Azole Antifungal [EPC] | 9 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 7 |
| 9 | Estrogen Receptor Antagonist [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Estrogen Receptor Antagonist [EPC] | 7 | 0.0002 |
| 6 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Aromatase Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |